Time to harness the pro-apoptotic property of NFκB?


We read with great interest the review article by Nakanishi and Toi1, in which the authors highlight the usefulness of nuclear factor-κB (NFκB) inhibitors in anticancer therapy. This is in line with the central theme of NFκB biology, which portrays NFκB as oncogenic and antiapoptotic. However, as the authors themselves briefly mention towards the end of the… (More)
DOI: 10.1038/nrc1588-c1


Cite this paper

@article{Radhakrishnan2006TimeTH, title={Time to harness the pro-apoptotic property of NFκB?}, author={Senthil K. Radhakrishnan and Sitharthan Kamalakaran}, journal={Nature Reviews Cancer}, year={2006}, volume={6}, pages={-} }